Development and Evaluation of buspirone hydrochloride nanoparticle temperature-sensitive gel for treating Generalized Anxiety Disorder

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Journal of Drug Delivery Science and Technology

• Publication date

  2025-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.jddst.2025.107487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal administration of berberine-loaded hydrogel ameliorates okadaic acid-induced cognitive deficit in mice

  2025cited by this paper
• Nose-to-brain drug delivery: from bench to bedside

  2025cited by this paper
• A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease

  2025cited by this paper
• Mucoadhesive in situ nasal gel of amoxicillin trihydrate for improved local delivery: ex vivo mucosal permeation and retention studies.

  2024cited by this paper
• In-situ gel injection of poloxamer-based metamizole provides long-acting antipyretic effects

  2024cited by this paper
• Structure-Inherent Tumor-Targeted IR-783 for Near-Infrared Fluorescence-Guided Photothermal Therapy

  2024cited by this paper
• Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery

  2024cited by this paper
• In-situ gel: A smart carrier for Drug Delivery.

  2024cited by this paper
• SCFAs Supplementation Rescues Anxiety- and Depression-like Phenotypes Generated by Fecal Engraftment of Treatment-Resistant Depression Rats.

  2024cited by this paper
• Tripolyphosphate-chitosan-pea protein interactions confers long-term stability to 3D printed high internal phase Pickering emulsions.

  2024cited by this paper
• Anxiety Disorders: Treatments, Models, and Circuitry Mechanisms.

  2024cited by this paper
• General deficits of attentional inhibition in high trait anxiety: ERP evidence.

  2023cited by this paper
• Preparation and characteristics of a thermosensitive in situ gel loaded with chitosan nanoparticles for optimal ocular delivery of chloramphenicol

  2023cited by this paper
• Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.

  2023cited by this paper
• Inorganic nano-drug delivery systems for crossing the blood–brain barrier: Advances and challenges

  2023cited by this paper
• Brain Mechanisms Underlying Panic Attack and Panic Disorder

  2023cited by this paper
• Chitosan: A review on properties, biological activities and recent progress in biomedical applications

  2023cited by this paper
• Advances in drug delivery systems, challenges and future directions

  2023cited by this paper
• Epidemiology of anxiety disorders: global burden and sociodemographic associations

  2023cited by this paper
• Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery

  2023cited by this paper
• In situ gelling drug delivery systems for topical drug delivery.

  2023cited by this paper
• Sustained co-delivery of 5-fluorouracil and cis-platinum via biodegradable thermo-sensitive hydrogel for intraoperative synergistic combination chemotherapy of gastric cancer

  2022cited by this paper
• Update on treatments for anxiety-related disorders

  2022cited by this paper
• Progress of Research in In Situ Smart Hydrogels for Local Antitumor Therapy: A Review

  2022cited by this paper
• Cellulose‐Based Biomaterials: Chemistry and Biomedical Applications

  2022cited by this paper
• Anxiety disorders.

  2021cited by this paper
• Central nervous system delivery of molecules across the blood-brain barrier.

  2021cited by this paper
• Impact of mind-body intervention on proinflammatory cytokines interleukin 6 and 1β: a three-arm randomized controlled trial for persons with sleep disturbance and depression.

  2021cited by this paper
• Danzhi Xiaoyao Powder Promotes Neuronal Regeneration by Downregulating Notch Signaling Pathway in the Treatment of Generalized Anxiety Disorder

  2021cited by this paper
• Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats

  2021cited by this paper
• Preparation of chitosan nanoparticles by ionotropic gelation technique: effects of formulation parameters and in vitro characterization

  2021cited by this paper
• Complex post-traumatic stress disorder.

  2021cited by this paper
• Application of response surface methodology (RSM) in statistical optimization and pharmaceutical characterization of a patient compliance effervescent tablet formulation of an antiepileptic drug levetiracetam

  2020cited by this paper
• Development of Carbamazepine Nanostructured Lipid Carrier Loaded Thermosensitive Gel for Intranasal Delivery

  2020cited by this paper
• Thermosensitive mucoadhesive in situ gel for intranasal delivery of Almotriptan malate: Formulation, characterization, and evaluation

  2020cited by this paper
• Ultratough graphene–black phosphorus films

  2020cited by this paper
• Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery

  2019cited by this paper
• Artificial Red Blood Cells Constructed by Replacing Heme with Perfluorodecalin for Hypoxia‐Induced Radioresistance

  2019cited by this paper
• Anxiety and Fear-Related Disorders in the ICD-11: Results from a Global Case-controlled Field Study.

  2019cited by this paper
• Poloxamer Hydrogels for Biomedical Applications

  2019cited by this paper
• Non-invasive delivery strategies for biologics

  2018cited by this paper
• Parameters influencing the size of chitosan-TPP nano- and microparticles

  2018cited by this paper
• An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems

  2018cited by this paper
• Activation of airway epithelial bitter taste receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-AMP, and nitric oxide signaling

  2018cited by this paper
• Crossing the blood‐brain barrier with nanoparticles

  2018cited by this paper
• Liposomes and polymersomes: a comparative review towards cell mimicking.

  2018cited by this paper
• The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior.

  2018cited by this paper
• Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview

  2018cited by this paper
• Somatic symptoms of anxiety and depression : a population-based study

  2017cited by this paper
• Anxiety disorders: a review of current literature

  2017cited by this paper
• Development, evaluation, and influence of formulation and process variables on in vitro performance of oral elementary osmotic device of atenolol

  2016cited by this paper
• Nasal Drug Delivery Systems: An Overview

  2015cited by this paper
• Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.

  2015cited by this paper
• Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.

  2014cited by this paper
• Generalized Anxiety Disorder

  2013cited by this paper
• Preparation, characterization and evaluation of selenite-loaded chitosan/TPP nanoparticles with or without zein coating

  2010cited by this paper
• Rapid and highly sensitive liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantitation of buspirone in human plasma: application to a pharmacokinetic study.

  2006cited by this paper
• Obsessive–compulsive disorder

  2000cited by this paper
• Intranasal mucociliary clearance of putative bioadhesive polymer gels

  1996cited by this paper
• The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery

  1991cited by this paper
• Preclinical Pharmacology of Buspirone Hydrochloride

  1984cited by this paper

• Preparation of a quercetin-loaded porous microsphere gel for the treatment of atopic dermatitis in BALB/c mice

  2026cites this paper
• Therapeutic innovation through drug repurposing: A multidimensional approach toward treating Parkinson's disease.

  2025cites this paper